News
1d
GlobalData on MSNPrasad’s FDA exit may accelerate cell and gene therapy approvalsVinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...
On July 2, linvoseltamab-gcpt (Lynozyfic; Regeneron) received an accelerated approval from the FDA in relapsed/refractory ...
Jacob Sands, MD, discusses the data that support the FDA accelerated approval of Dato-DXd in EGFR-positive non–small cell ...
The analysis of FDA-approved next-in-class drugs also found that, among RCTs with head-to-head trials, fewer than 1 in 4 of ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...
The iBox Scoring System is a novel composite biomarker endpoint predictive of long-term graft survival after kidney ...
This will pave the way for accelerated infrastructure development and planned growth in nearby villages, officials said.
Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - ...
The annual rate of house price growth accelerated to 2.4% on average in July, Nationwide Building Society said.
Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne's first planned ...
The annual rate of house price growth accelerated to 2.4% on average in July, Nationwide Building Society said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results